{"nct_id":"NCT06868667","title":"Japan Expansion Cohort: Evaluation of Efficacy and Safety of Belantamab Mafodotin, Bortezomib and Dexamethasone Versus Daratumumab, Bortezomib and Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-05","start_date":"2021-07-28","start_date_type":"ACTUAL","primary_completion_date":"2024-04-03","primary_completion_date_type":"ACTUAL","completion_date":"2026-06-19","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["GSK"]}